DPP4 and pulmonary fibrosis: In a mouse model of pulmonary fibrosis after systemic endotoxin damage, endothelial to mesenchymal transition (EndMT) was shown in endothelial cells overexpressing DPP-4(Vildagliptin), which has been reported to alleviate pulmonary fibrosis.